title: Patients with relapsed follicular lymphoma treated with rituximab versus tositumomab and iodine I-131 tositumomab.
authors.affiliation: St. Mary Medical Center , Walla Walla, WA , USA.
authors.forename: Robert C
authors.initials: RC
authors.lastname: Quackenbush
authors.forename: Thierry J
authors.initials: TJ
authors.lastname: Horner
authors.forename: Vanessa C
authors.initials: VC
authors.lastname: Williams
authors.forename: Patricia
authors.initials: P
authors.lastname: Giampietro
authors.forename: Thomas S
authors.initials: TS
authors.lastname: Lin
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D005334:Fever / Q000209:etiology; D006261:Headache / Q000209:etiology; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use; D053208:Kaplan-Meier Estimate; D008224:Lymphoma, Follicular / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000209:etiology; D009364:Neoplasm Recurrence, Local; D016499:Radioimmunotherapy / Q000379:methods; D000069283:Rituximab / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D007457:Iodine Radioisotopes; D000069283:Rituximab; C119496:tositumomab I-131